Evidence map›Paper›PMID 25078278›Full record

ArticlePloS one2014

Involvement of fatty acid amide hydrolase and fatty acid binding protein 5 in the uptake of anandamide by cell lines with different levels of fatty acid amide hydrolase expression: a pharmacological study.

Emmelie Björklund, Anders Blomqvist, Joel Hedlin, Emma Persson, Christopher J Fowler

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Mechanisms of endocannabinoid transport in the brain.British journal of pharmacology · 2022
    Review
  2. Article
  3. Review
  4. Cannabidiol's Upregulation ofCannabis and cannabinoid research · 2018
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Emmelie BjörklundDepartment of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.
Anders BlomqvistDepartment of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.
Joel HedlinDepartment of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.
Emma PerssonDepartment of Radiation Sciences, Umeå University, Umeå, Sweden.
Christopher J FowlerDepartment of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.
Umeå University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe endocannabinoid ligand anandamide (AEA) is removed from the extracellular space by a process of cellular uptake followed by metabolism. In many cells, such as the RBL-2H3 cell line, inhibition of FAAH activity reduces the observed uptake, indicating that the enzyme regulates uptake by controlling the intra- : extracellular AEA concentration gradient. However, in other FAAH-expressing cells, no such effect is seen. It is not clear, however, whether these differences are methodological in nature or due to properties of the cells themselves. In consequence, we have reinvestigated the role of FAAH in gating the uptake of AEA. METHODOLOGY/PRINCIPAL

findingsThe effects of FAAH inhibition upon AEA uptake were investigated in four cell lines: AT1 rat prostate cancer, RBL-2H3 rat basophilic leukaemia, rat C6 glioma and mouse P19 embryonic carcinoma cells. Semi-quantitative PCR for the cells and for a rat brain lysate confirmed the expression of FAAH. No obvious expression of a transcript with the expected molecular weight of FLAT was seen. FAAH expression differed between cells, but all four could accumulate AEA in a manner inhibitable by the selective FAAH inhibitor URB597. However, there was a difference in the sensitivities seen in the reduction of uptake for a given degree of FAAH inhibition produced by a reversible FAAH inhibitor, with C6 cells being more sensitive than RBL-2H3 cells, despite rather similar expression levels and activities of FAAH. The four cell lines all expressed FABP5, and AEA uptake was reduced in the presence of the FABP5 inhibitor SB-FI-26, suggesting that the different sensitivities to FAAH inhibition for C6 and RBL2H3 cells is not due to differences at the level of FABP-5. CONCLUSIONS/SIGNIFICANCE: When assayed using the same methodology, different FAAH-expressing cells display different sensitivities of uptake to FAAH inhibition.

Indexed as

AmidohydrolasesAnimalsArachidonic AcidsCell Line, TumorEndocannabinoidsEye ProteinsFatty Acid Amide HydrolasesFatty Acid-Binding ProteinsNerve Tissue ProteinsPolymerase Chain ReactionPolyunsaturated AlkamidesRatsAmidohydrolasesanandamideArachidonic AcidsEndocannabinoidsEye ProteinsFabp5 protein, ratFatty Acid Amide HydrolasesFatty Acid-Binding ProteinsNerve Tissue ProteinsPolyunsaturated Alkamides

Identifiers

PMID25078278
PMCPMC4117496
OpenAlexW2045985680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.